Filing Details
- Accession Number:
- 0001567619-20-011016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-22 16:30:26
- Reporting Period:
- 2020-05-20
- Accepted Time:
- 2020-05-22 16:30:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1512762 | Coherus Biosciences Inc. | CHRS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1427569 | Jean-Frederic Viret | Coherus Biosciences, Inc. 333 Twin Dolphin Drive, Suite 600 Redwood City CA 94065 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.0001 Par Value | Disposition | 2020-05-20 | 1,278 | $17.66 | 46,567 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person.
- Includes 31,250 restricted stock units.
- Includes 1,004 shares acquired on May 15, 2020, pursuant to Issuer's employee stock purchase plan.